Immune-Calming therapy shows promise for hair loss

NCT ID NCT02557074

Completed Disease control Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Mar 25, 2026 · Last updated May 16, 2026 · Updated 6 times

Summary

This study tested whether low doses of IL2, a protein that helps regulate the immune system, could treat severe alopecia areata (patchy hair loss). 44 adults with at least 50% scalp hair loss that did not respond to standard treatments received either IL2 or a placebo. The goal was to see if IL2 could safely reduce hair loss to 25% or less of the scalp after 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

AP-HM - La timone - Dermatologie

Marseille, Bouche Du Rhône, 13005, France
AP-HP St Louis - Dermatologie

Paris, Île-de-France Region, 75000, France
CHI St Raphael Fréjus - Dermatologie

Fréjus, PACA, 83000, France
CHU Montpellier - Dermatologie

Montpellier, 34000, France
CHU de Nice - dermatologie

Nice, 06200, France
CHU de Nimes - Dermatologie

Nîmes, Languedoc-Roussillon, 30000, France

Conditions

Explore the condition pages connected to this study.

ALOPECIA AREATA